Allspring Global Investments Holdings LLC Decreases Stake in Zepp Health Co. (NYSE:ZEPP)

Allspring Global Investments Holdings LLC cut its stake in shares of Zepp Health Co. (NYSE:ZEPP) by 2.5% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 5,004,734 shares of the company’s stock after selling 129,476 shares during the quarter. Allspring Global Investments Holdings LLC owned about 8.16% of Zepp Health worth $7,107,000 as of its most recent SEC filing.

Several other hedge funds have also recently made changes to their positions in ZEPP. Envestnet Asset Management Inc. acquired a new stake in Zepp Health during the 1st quarter valued at approximately $49,000. Citadel Advisors LLC acquired a new position in Zepp Health during the third quarter valued at $30,000. Rhumbline Advisers boosted its holdings in Zepp Health by 791.3% in the third quarter. Rhumbline Advisers now owns 30,215 shares of the company’s stock valued at $35,000 after purchasing an additional 26,825 shares during the last quarter. Renaissance Technologies LLC acquired a new stake in Zepp Health during the 1st quarter worth about $107,000. Finally, Susquehanna International Group LLP raised its stake in shares of Zepp Health by 40.0% during the 1st quarter. Susquehanna International Group LLP now owns 40,094 shares of the company’s stock valued at $53,000 after buying an additional 11,451 shares during the last quarter. 52.61% of the stock is owned by institutional investors and hedge funds.

Zepp Health Stock Performance

ZEPP opened at $0.83 on Thursday. The firm has a fifty day moving average price of $1.11 and a 200 day moving average price of $1.24. Zepp Health Co. has a 1 year low of $0.82 and a 1 year high of $2.10. The stock has a market cap of $50.64 million, a P/E ratio of -1.68 and a beta of 0.81. The company has a debt-to-equity ratio of 0.34, a current ratio of 2.04 and a quick ratio of 1.49.

Zepp Health (NYSE:ZEPP) last issued its quarterly earnings data on Monday, March 18th. The company reported ($0.02) earnings per share for the quarter. Zepp Health had a negative return on equity of 8.55% and a negative net margin of 8.66%. The firm had revenue of $84.47 million during the quarter.

Analysts Set New Price Targets

Separately, Fundamental Research set a $4.96 target price on Zepp Health and gave the stock a “buy” rating in a report on Tuesday, March 26th.

Zepp Health Profile

Zepp Health Corporation operates as a smart wearable and health technology company worldwide. It empowers users to live lives by optimizing health, fitness, and wellness journeys through its consumer brands, Amazfit, Zepp Clarity, and Zepp Aura. The company through its proprietary Zepp Digital Management Platform, which includes the Zepp OS, AI chips, biometric sensors, and data algorithms, delivers cloud-based 24/7 actionable insights and guidance to help users attain wellness goals.